These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10390397)

  • 21. Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis: an outcome and cost-effectiveness analysis.
    Jasmer RM; Snyder DC; Chin DP; Hopewell PC; Cuthbert SS; Antonio Paz E; Daley CL
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1648-52. PubMed ID: 11069790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community.
    Lorvick J; Thompson S; Edlin BR; Kral AH; Lifson AR; Watters JK
    J Urban Health; 1999 Dec; 76(4):461-7. PubMed ID: 10609595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Directly observed isoniazid preventive therapy for released jail inmates.
    Nolan CM; Roll L; Goldberg SV; Elarth AM
    Am J Respir Crit Care Med; 1997 Feb; 155(2):583-6. PubMed ID: 9032198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.
    Alaei K; Alaei A; Mansouri D
    East Mediterr Health J; 2002 Nov; 8(6):754-7. PubMed ID: 15568452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand?
    Sheerin IG; Green FT; Sellman JD
    Drug Alcohol Rev; 2004 Sep; 23(3):261-72. PubMed ID: 15370005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants.
    Porco TC; Lewis B; Marseille E; Grinsdale J; Flood JM; Royce SE
    BMC Public Health; 2006 Jun; 6():157. PubMed ID: 16784541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-step tuberculin skin testing in drug users.
    Swaminathan S; Schoenbaum EE; Klein RS; Howard AA; Lo Y; Gourevitch MN
    J Addict Dis; 2007; 26(2):71-9. PubMed ID: 17595000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
    Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective.
    Bell JC; Rose DN; Sacks HS
    AIDS; 1999 Aug; 13(12):1549-56. PubMed ID: 10465080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-utility of tuberculosis prevention among HIV-infected adults in Kampala, Uganda.
    Shrestha RK; Mugisha B; Bunnell R; Mermin J; Odeke R; Madra P; Hitimana-Lukanika C; Adatu-Engwau F; Blandford JM
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):747-54. PubMed ID: 17609049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics.
    Tran BX; Ohinmaa A; Duong AT; Nguyen LT; Vu PX; Mills S; Houston S; Jacobs P
    Drug Alcohol Depend; 2012 Oct; 125(3):260-6. PubMed ID: 22436971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
    Diel R; Wrighton-Smith P; Zellweger JP
    Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis.
    Gourevitch MN; Hartel D; Selwyn PA; Schoenbaum EE; Klein RS
    AIDS; 1999 Oct; 13(15):2069-74. PubMed ID: 10546859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection.
    Chaisson RE; Clermont HC; Holt EA; Cantave M; Johnson MP; Atkinson J; Davis H; Boulos R; Quinn TC; Halsey NA
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1034-8. PubMed ID: 8887603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is cough alone adequate to screen HIV-positive persons for tuberculosis preventive therapy in developing countries?
    Hawken M; Ngángá L; Meme H; Chakaya J; Porter J
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):540-1. PubMed ID: 10383070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR; Brehm WT; Moore RD; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia.
    Afriandi I; Siregar AY; Meheus F; Hidayat T; van der Ven A; van Crevel R; Baltussen R
    Health Policy; 2010 Apr; 95(1):69-73. PubMed ID: 20004491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
    Flaherman VJ; Porco TC; Marseille E; Royce SE
    Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.